Jolie Siegel - Chief Legal Officer at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Issuer Symbol
CCCC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jolie Siegel since 11 Mar 2025

Holdings reported by Jolie Siegel for C4 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 107,939 $343,246 $3.18 14 Feb 2025 Direct
Performance Restricted Stock Units 10,500 $63,420 $6.04 07 Nov 2024 Direct Common Stock
Stock Option (Right to Buy) 84,700 14 Feb 2025 Direct Common Stock

Transactions reported by Jolie Siegel for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.